Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Pharmaceutical Resource Technology, Inc.

CIK 1865759Updated Nov 6, 2026

Name history
Jaison Phytochem, Inc. · through Jun 16, 2022

No exchange listing on record for this SEC filer. Coverage is drawn from its filings.

Filing activity

SEC EDGAR
Latest filing

10-Q · Nov 4, 2026

13 filings on record · 10-Q, 10-Q/A, 424B3, EFFECT, S-1/A, S-1.

Recent filings

  1. 10-Q filing

    10-Q · 2026-11-04 · 0001477932-26-006633

  2. 10-Q/A filing

    10-Q/A · 2026-10-30 · 0001477932-26-006534

  3. 10-Q filing

    10-Q · 2026-08-03 · 0001477932-26-004658

  4. 424B3 filing

    424B3 · 2026-06-24 · 0001477932-26-003969

  5. EFFECT filing

    EFFECT · 2026-06-23 · 9999999995-26-002086

Show 5 more recent filings
  1. S-1/A filing

    S-1/A · 2026-06-09 · 0001477932-26-003701

  2. S-1/A filing

    S-1/A · 2026-05-22 · 0001477932-26-003401

  3. S-1/A filing

    S-1/A · 2026-04-28 · 0001477932-26-002599

  4. S-1/A filing

    S-1/A · 2026-04-03 · 0001477932-26-001989

  5. S-1 filing

    S-1 · 2026-02-11 · 0001477932-26-000746

Offerings

Registration 333-293366

S-1/A · 2026-06-09 · 0001477932-26-003701

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

pharmaceutical_ex107.htm · S-1 · 2026-02-11

EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) PHARMACEUTICAL RESOURCE TECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Security Type Security Fee Amount Proposed Proposed Fee Rate Amount of Class Title Calculation …

S-1 · 2026-02-11 · 0001477932-26-000746

Read attachment ↗
pharmaceutical_ex41.htm · S-1 · 2026-02-11

EXHIBIT 4.1 All certificates to be transferred must be enclosed with this stock power The signature to (his assignment must correspond with the name as written upon the face of the certificate in every particular without alteration or enlargement or any change whatsoever. The signature of the person executing this power must be guaranteed by an eligible Guarantor Institution such as a Commercial Bank, Trust Company, Securities Broker/Dealer, Credit Union, or Savings Association participating i…

S-1 · 2026-02-11 · 0001477932-26-000746

Read attachment ↗
pharmaceutical_ex991.htm · S-1 · 2026-02-11

EXHIBIT 99.1 SUBSCRIPTION AGREEMENT The undersigned (the “Subscriber”), desires to become a holder of common shares (the “Shares”) of PHARMACEUTICAL RESOURCE TECHNOLOGY, INC a corporation organized under the laws of the state of Wyoming (the “Company”); one share of Common Stock has a par value $0.01 per share. Accordingly, the Subscriber hereby agrees as follows: 1. Subscription. 1.1 The Subscriber hereby subscribes for and agrees to accept from the Company that number of Shares set …

S-1 · 2026-02-11 · 0001477932-26-000746

Read attachment ↗
pharmaceutical_ex992.htm · S-1 · 2026-02-11

EXHIBIT 99.2

S-1 · 2026-02-11 · 0001477932-26-000746

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.